Product
Pegylated Interferon-alfa 2a
1 clinical trial
1 indication
Indication
Chronic Hepatitis BClinical trial
A Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of VIR-2218 Alone or in Combination With Pegylated Interferon Alpha-2aStatus: Active (not recruiting), Estimated PCD: 2024-03-25